Alyeska Investment Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Alyeska Investment Group’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.66M	Buy	73,959 +39,908	+117%	+$4.01M	0.02%	447
2026 Q1	$3.15M	Buy	+34,051	New	+$3.2M	0.01%	523
2021 Q1	–	Sell	-99,421	Closed	-$1.74M	–	796
2020 Q4	$1.74M	Buy	99,421 +49,443	+99%	+$972K	0.02%	384
2020 Q3	$963K	Sell	49,978 -38,406	-43%	-$824K	0.01%	390
2020 Q2	$1.72M	Sell	88,384 -57,327	-39%	-$958K	0.03%	369
2020 Q1	$2.04M	Buy	145,711 +118,631	+438%	+$1.95M	0.04%	256
2019 Q4	$664K	Sell	27,080 -48,097	-64%	-$513K	0.01%	342
2019 Q3	$756K	Buy	+75,177	New	+$922K	0.01%	339

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group's MIRM Position: Q2 2026 in Review

Alyeska Investment Group increased its Mirum Pharmaceuticals (MIRM) stake by 117% in Q2 2026, buying an estimated $4.01M and bringing the position to 73,959 shares worth $8.66M. The position accounts for 0.02% of the portfolio, ranked #447.

Alyeska Investment Group first reported a position in MIRM in Q3 2019 and has held it in 8 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Alyeska Investment Group held 73,959 shares of Mirum Pharmaceuticals worth $8.66M as of Q2 2026.
Alyeska Investment Group bought 39,908 Mirum Pharmaceuticals shares in Q2 2026, an estimated $4.01M.
Mirum Pharmaceuticals made up 0.02% of Alyeska Investment Group's portfolio in Q2 2026, its #447 holding.
Alyeska Investment Group first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 8 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.